title: Deficiency of connexin43 gap junctions is an independent marker for breast tumors.
abstract: Gap junctions are intercellular channels that are formed from members of a family of proteins, the connexins (Cxs). Gap junctions play an important role in vital functions, including the regulation of cell growth and cell differentiation. Here, we examined the expression of Cx43, a major Cx in breast tissue, in 32 surgical specimens obtained from breast cancer patients who underwent a primary surgical resection prior to chemotherapy or radiotherapy treatments. The expression of Cx43 gap junctions was compared to the levels of estrogen, progesterone, and erbB2 tyrosine kinase receptors. In addition, a panel of breast cancer cell lines and a series of normal rat mammary tissues and rat mammary tumors induced in vivo by dimethylbenz(a)anthracene were studied. We demonstrated that the lack of Cx43 gap junctions is a common feature of human mammary cancer tissues compared to nonneoplastic breast tissues surrounding primary tumors. Cx43 gap junctions were not observed in ductal carcinomas in situ, infiltrating ductal carcinomas, and infiltrating lobular carcinomas, and they seem to be independent of estrogen, progesterone, and erbB2 receptor status. In breast cancer cell lines and rodent mammary carcinoma tissues, down-regulation of Cx43 occurs at the mRNA level, suggesting a transcriptional mechanism for the decrease of Cx43 protein in breast cancer. In summary, this study provides evidence of decreased expression of Cx43 gap junctions in breast cancer at various stages of progression as well as breast cancer cell lines and raises the possibility that Cx43 may be a useful marker for detecting early oncogenesis in the breast. Because Cx43 gap junctions are lacking in breast cancer and restoration of Cx43 has been shown to reverse the malignant phenotype in vitro, pharmacological up-regulation of Cx43 may prove beneficial in cancer therapeutics.
authors.affiliation: McGill Centre for Translational Research in Cancer, Lady Davis Institute for Medical Research, and Department of Medicine, Faculty of Medicine, McGill University, Montreal, Quebec, Canada.
authors.forename: D W
authors.initials: DW
authors.lastname: Laird
authors.forename: P
authors.initials: P
authors.lastname: Fistouris
authors.forename: G
authors.initials: G
authors.lastname: Batist
authors.forename: L
authors.initials: L
authors.lastname: Alpert
authors.forename: H T
authors.initials: HT
authors.lastname: Huynh
authors.forename: G D
authors.initials: GD
authors.lastname: Carystinos
authors.forename: M A
authors.initials: MA
authors.lastname: Alaoui-Jamali
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000818:Animals; D014408:Biomarkers, Tumor; D001943:Breast Neoplasms / Q000378:metabolism* / Q000473:pathology; D018031:Connexin 43 / Q000172:deficiency*; D015536:Down-Regulation; D005260:Female; D006801:Humans; D007150:Immunohistochemistry; D015674:Mammary Neoplasms, Animal / Q000378:metabolism* / Q000473:pathology; D008875:Middle Aged; D051381:Rats; D014407:Tumor Cells, Cultured
chemical_list: D014408:Biomarkers, Tumor; D018031:Connexin 43